Start free

Boston Scientific Corp (BSX) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 6, 2026.

Filings shown
27
Open-market buys
10
Open-market sells
0
Buys, 10b5-1 box not checked
10 of 10

Counts cover the 27 most recent Form 4 filings Tradune holds for BSX (filed May 4 – Nov 6, 2026); the score below covers only the trailing 90 days (1 buy, 0 sells). SEC EDGAR Form 4 filings for BSX last checked Nov 14, 2026, 09:00 UTC; the latest BSX filing Tradune holds was filed Nov 6, 2026. This is not guaranteed to be the complete record — see BSX's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 4 filings Tradune holds for BSX filed Aug 26 – Nov 6, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Susan E. MoranoDirector 1 0 2,040 — +$100,408

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

56/ 100

Net insider purchases
1 distinct buyer1 buy · 0 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

Weekly signal history

BSX appeared in 6 archived weekly editions as a multi-insider cluster, a top net buyer, or both. These are frozen weekly snapshots, not a complete filing history.

  1. Week of Oct 28, 2026
    4 insiders buying · $9,486,038 net
  2. Week of Oct 7, 2026
    4 insiders buying · $9,486,038 net
  3. Week of Sep 30, 2026
    4 insiders buying · $9,486,038 net
  4. Week of Sep 23, 2026
    4 insiders buying · $9,486,038 net 6 open-market buys · $9,486,038 net
  5. Week of Sep 16, 2026
    4 insiders buying · $9,486,038 net 6 open-market buys · $9,486,038 net
  6. Week of Sep 9, 2026
    4 insiders buying · $9,486,038 net 6 open-market buys · $9,486,038 net

An entry means this company met that edition’s displayed cluster or top-buyer threshold. Missing weeks do not mean no insider transaction occurred. All figures are derived from SEC Form 4 filings; open-market buys minus sales are shown as net only when every transaction value was disclosed.

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at BSX

Insiders reported 10 open-market purchases of BSX between May 4, 2026 and Nov 6, 2026, across 5 distinct buyers. The most recent purchase was reported by Susan E. Morano (Director) on Aug 25, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Michael F. Mahoney Chairman, President & CEO · filed Nov 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Gift 149,992 — 149,992 (indirect) — Nov 4, 2026
Gift 102,249 — 252,241 (indirect) +68% Nov 4, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

Miriam O'Sullivan SVP, Chief HR Officer · filed Nov 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 3,871 — 21,437 +22% Nov 1, 2026
Tax withholding 1,872 $41.98 19,565 −8.7% Nov 1, 2026
Option exercise Restricted Stock Units 3,871 — — — Nov 1, 2026
Padraig Andrew O'Connor EVP, Global Operations · filed Sep 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 567 $48.37 7,892 −6.7% Sep 2, 2026
Option exercise Restricted Stock Units 1,171 — — — Sep 2, 2026
Option exercise 1,171 — 8,459 +16% Sep 2, 2026
Susan E. Morano Director · filed Aug 26, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,040 $49.22 13,784 +17% Aug 25, 2026

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Emily Woodworth SVP, Global Controller and CAO · filed Aug 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Discretionary transaction 2,930 $51.19 2,930 (indirect) — Aug 11, 2026
Jonathan Monson EVP and CFO · filed Aug 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Discretionary transaction 9,908 $50.46 9,908 (indirect) — Aug 10, 2026
David C. Habiger Director · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,100 $47.59 17,160 +14% Aug 5, 2026
David C. Habiger Director · filed Aug 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 140 $48.59 15,060 +0.9% Aug 4, 2026
Open-market purchase 10b5-1 box not checked 1,042 $48.07 14,920 +7.5% Aug 3, 2026
Michael F. Mahoney Chairman, President & CEO · filed Aug 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 186,240 $48.33 1,590,024 +13% Aug 3, 2026
Discretionary transaction 22,119 $48.43 22,119 (indirect) — Aug 3, 2026
Edward J. Ludwig Director · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 5,000 $45.48 30,359 +20% Jul 31, 2026
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Discretionary transaction 64,198 $46.73 64,198 (indirect) — Jul 31, 2026
Jonathan Monson EVP and CFO · filed Jul 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Restricted Stock Units 2,087 — — — Jul 1, 2026
Option exercise 2,087 — 40,073 +5.5% Jul 1, 2026
Tax withholding 1,010 $43.06 39,063 −2.5% Jul 1, 2026
Michael F. Mahoney Chairman, President & CEO · filed Jun 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Gift 386,755 — 0 (indirect) −100% May 28, 2026
Cheryl Pegus Director · filed May 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,770 $56.49 1,770 — May 20, 2026
Edward J. Ludwig Director · filed May 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 3,580 $56.68 25,359 +16% May 20, 2026
David C. Habiger Director · filed May 21, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,250 $55.92 13,878 +19% May 20, 2026
Open-market purchase 10b5-1 box not checked 2,200 $56.95 11,628 +23% May 19, 2026
Ellen M. Zane Director · filed May 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,800 — 27,934 +16% May 7, 2026
David S. Wichmann Director · filed May 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,800 — 45,382 +9.1% May 7, 2026
Christophe Pierre Weber Director · filed May 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Deferred Stock Units 2,660 — — — May 7, 2026
Grant / award 1,767 — 2,646 +201% May 7, 2026
Grant / award 1,140 — 3,786 +43% May 7, 2026
Cathy R. Smith Director · filed May 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Deferred Stock Units 3,800 — — — May 7, 2026
Grant / award Deferred Stock Units 2,209 — — — May 7, 2026
Cheryl Pegus Director · filed May 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Deferred Stock Units 3,800 — — — May 7, 2026
Grant / award Deferred Stock Units 1,281 — — — May 7, 2026
Susan E. Morano Director · filed May 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,800 — 10,463 +57% May 7, 2026
Grant / award 1,281 — 11,744 +12% May 7, 2026
Jessica L. Mega Director · filed May 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,800 — 12,035 +46% May 7, 2026
Edward J. Ludwig Director · filed May 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,800 — 21,779 +21% May 7, 2026
David C. Habiger Director · filed May 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 3,800 — 9,428 +68% May 7, 2026

Listing the 25 most recent of 27 Form 4 filings held for BSX; the 2 older filings (filed May 4 – May 4, 2026) are counted above but not listed here — see BSX's full Form 4 filing history on SEC EDGAR.

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to BSX's (Nov 6, 2026).

Frequently asked about BSX insider activity

How many insiders bought BSX stock in these Form 4 filings?

5 distinct insiders at Boston Scientific Corp reported 10 open-market purchases (Form 4 code P) of BSX shares between May 4, 2026 and Nov 6, 2026, the most recent filed by Susan E. Morano (Director) on Aug 25, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for BSX?

The most recent Form 4 on this page was filed by Michael F. Mahoney (Chairman, President & CEO) on Nov 6, 2026, reporting 2 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market BSX insider purchase shown?

The largest open-market purchase among the filings shown was 186,240 BSX shares at $48.33 (about $9,001,408) by Michael F. Mahoney (Chairman, President & CEO) on Aug 3, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent BSX insider purchases have the Form 4 10b5-1 box checked?

No. All 10 BSX open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Susan E. Morano (Director) on Aug 25, 2026, 2,040 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for BSX — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.